Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up

J C Andrews, S C Walker, R J Ackermann, L A Cotton, W D Ensminger, B Shapiro
1994 Journal of Nuclear Medicine  
The treatment of hepatic tumors remains unsatisfactory. These lesions receive most of their blood supply from the hepatic artery, therefore the hepatic artery administration of beta-emitting particulate radiopharmaceuticals is an attractive approach to deliver therapeutic irradiation to the liver and differentially to tumors within the liver.
pmid:7931662 fatcat:ci5am3tn4zfbxla2oxmvu3hhii